SCHEMBL4841792

SCHEMBL4841792

COc1ccc(C(=O)c2c(OC)cc(OC)cc2C(=O)O)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.62
ALDH1A1 P00352 2/20 0.61
MAPT P10636 3/20 0.59
NPSR1 Q6W5P4 2/20 0.59
HTT P42858 1/20 0.59
GAA P10253 1/20 0.55
KMT2A Q03164 3/20 0.55
TUBB4A P04350 1/20 0.54
TUBB P07437 1/20 0.54
TUBA3C P0DPH7 1/20 0.54
TUBA1B P68363 1/20 0.54
TUBA4A P68366 1/20 0.54
TUBB4B P68371 1/20 0.54
TUBB3 Q13509 1/20 0.54
TUBB2A Q13885 1/20 0.54
TUBB8 Q3ZCM7 1/20 0.54
TUBA3E Q6PEY2 1/20 0.54
TUBA1A Q71U36 1/20 0.54
TUBA1C Q9BQE3 1/20 0.54
TUBB6 Q9BUF5 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6507929 0.83 SMN1; SMN2 (0.53) ALDH1A1MAPTNPSR1HTTKMT2A
SCHEMBL7454965 0.81 CA1 (0.56) NPC1ALDH1A1MAPTNPSR1HTT
SCHEMBL4124832 0.79 NPC1 (0.68) NPC1ALDH1A1MAPTNPSR1HTT
SCHEMBL2288468 0.78 MAPT (0.54) NPC1ALDH1A1MAPTNPSR1HTT
SCHEMBL8476234 0.78 ALDH1A1 (0.70) NPC1ALDH1A1MAPTNPSR1HTT
SCHEMBL8481431 0.77 ALDH1A1 (0.56) NPC1ALDH1A1MAPTNPSR1HTT
SCHEMBL29414999 0.77 NPC1 (1.00) NPC1ALDH1A1MAPTNPSR1HTT
SCHEMBL6375687 0.77 MAPT (0.96) NPC1ALDH1A1MAPTNPSR1HTT
SCHEMBL5902231 0.77 NPC1 (1.00) NPC1ALDH1A1MAPTNPSR1HTT
SCHEMBL7481917 0.77 ALDH1A1 (0.62) NPC1ALDH1A1MAPTNPSR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423030-B2 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof SANOFI-AVENTIS (FR) 2008-09-09 US disclosed
US-20070099895-A1 1-AMINO-PHTHALAZINE DERIVATIVES, THE PREPARATION AND THE THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2007-05-03 US disclosed
CN-1953972-A 1-amino-phthalazine derivatives, their preparation and their therapeutic use SANOFI AVENTIS (FR) 2007-04-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099895-A1 1-AMINO-PHTHALAZINE DERIVATIVES, THE PREPARATION AND THE THERAPEUTIC USE THEREOF CYP11B2, CYP11B1, GOT2 NPC1 204/4885ALDH1A1 86/4885MAPT 459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.